Mariana Cunha

Mariana Cunha

Auto-generated profile, based on publicly available information

Mariana Cunha

Centre for Reproductive Genetics Prof. Alberto Barros, Porto, Portugal

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TSTânia Santos
Tânia Santos
APAna S. Pires-Luís
Ana S. Pires-Luís
ACAna Calado
Ana Calado
EOElsa Oliveira
Elsa Oliveira
MCMariana Cunha
Mariana Cunha
MSMário Sousa
Mário Sousa
The ultrastructure of human oocytes has been described only qualitatively. To offer a precise organelle spatial distribution and organelle volume during the main maturation stages, we previously conducted stereological studies on prophase-I (GV) and metaphase-I (MI) oocytes, and here we present results on metaphase-II (MII) oocytes. Five donor oocytes from different donors were processed for transmission electron microscopy, and quantification of organelle distribution was performed using point-counting stereology. Statistical tests compared the means of the relative volumes occupied by organelles among oocyte regions. The most abundant organelles were elements of the smooth endoplasmic reticulum (SER), such as SER small vesicles, SER medium vesicles, SER large vesicles and SER isolated tubules, along with mitochondria, followed by SER tubular aggregates, cortical vesicles and lysosomes. Significant differences between oocyte regions were found for lysosomes, cortical vesicles and SER large vesicles. Comparisons of MII oocytes to previous findings in GV and MI oocytes evidenced specific patterns of organelle distribution and relative volumes. This final evaluation thus enables to track organelle spatial reorganization across oocyte stages, which, in addition to gathered knowledge, may be useful to assist in improvements of stimulation protocols, in-vitro maturation media and cryopreservation techniques.

12 April 2025 in Andrology
Verified
Journal Article
Closed access
MPMariana Pereira
Mariana Pereira
MCMariana Cunha
Mariana Cunha
JSJoaquina Silva
Joaquina Silva
PVPaulo Viana
Paulo Viana
NBNuno Barros
Nuno Barros
MSMário Sousa
Mário Sousa

1 October 2025 in Reproduction and Fertility
Verified
Journal Article
Open access
MGMaria Gonçalves
Maria Gonçalves
MCMariana Cunha
Mariana Cunha
JSJosé Teixeira da Silva
José Teixeira da Silva
JSJoaquina Silva
Joaquina Silva
PVPaulo Viana
Paulo Viana
MSMário Sousa
Mário Sousa
Graphical Using a large patient series, we aimed to evaluate, in a high-responder population, the effect of triggering oocyte maturation with human choriogonadotropin (hCG) or with a gonadotropin-releasing hormone agonist (GnRHa). We analyzed data from 683 intended fresh embryo transfer cycles (ETCs) and 534 frozen-thawed embryo transfer (FET) cycles. The rates of ovarian hyperstimulation syndrome (OHSS), and the embryological, clinical, and newborn outcomes were compared. Considering the type of oocyte maturation trigger and embryo destination, cycles were divided into five groups. Cycles using an hCG-trigger, with progesterone luteal support, had fresh embryo transfer or embryo freeze-all (FA). Cycles using GnRHa/agonist-trigger, with hCG, estrogen, and progesterone luteal support, had fresh embryo transfer or embryo FA. The fifth group consisted of agonist-trigger cycles, without luteal support, that underwent embryo FA. Severe OHSS only occurred in fresh ETC, with the agonist-trigger evidencing a non-significantly lower rate. The FA groups evidenced higher numbers of retrieved oocytes and blastocyst rates. In fresh ETC, the Ag-fresh-hCG group evidenced higher implantation and clinical pregnancy rates. No differences were observed in clinical outcomes after FET, but cumulative clinical outcomes showed higher clinical pregnancy and newborn rates in the Ag-fresh-hCG group. After multivariable logistic regression analysis, these differences were not observed. The present results thus suggest that, in high-responders, the use of a GnRHa-trigger with luteal hCG in a fresh ETC presents similar outcomes relative to the use of an hCG-trigger. Data also suggest that FA should be applied to all suspected OHSS cases. Lay summary: Ovarian hyperstimulation syndrome (OHSS) is a complication of medically assisted reproduction treatments that may require hospitalization. In the presence of high risk to develop OHSS, embryo transfer can be canceled and embryos frozen to be used in a later cycle. Alternatively, a newer drug, an agonist, can be used for egg trigger in association with endometrium special preparation. Some characteristics make women more susceptible to develop OHSS. In this group of patients, we observed that the use of an agonist as egg trigger did not decrease pregnancy outcomes and that the option of freezing all embryos followed by embryo transfer in a later cycle abolished development of OHSS with hospitalization.